2023-04-07
CTBE Selected for AMED “Advanced Medical Devices and Systems Development Project”
CTBE is pleased to inform you that we have been selected for the AMED “System Development Project: Complementing Physical Functions and Improving QOL”. As a result, we will receive support for development costs of up to 575 million yen over the next five years.
We will accelerate the development of the world's first decellularized tissue-based medical device that reconstructs the torn rotator cuff and restores motor function.
2024-12-24
CoreTissue BioEngineering announces the renewal of its corporate website
2024-11-11
Yoji Jokura will present at ”The 62nd Annual Meeting of the Japanese Society for Artificial Organs”
2024-10-15
CTBE has been selected as a coworking member of the Japan Innovation Campus in Silicon Valley, USA.
2024-08-29
CTBE announces start of clinical trial for regenerative ligament for ACL reconstruction using decellularization technology
2024-07-30
Japanese medtech startup, CoreTissue BioEngineering, becomes first company accepted into accelerator program backed by Mitsubishi Corporation (Americas) and Fogarty Innovation